Open-label placebo improves symptoms in pediatric IBS and functional abdominal painFebruary 2, 2022Anxiety DisordersPediatricsPainSomatic Disorders
OTC cannabidiol products tied to improved pain, sleep, anxietyJanuary 24, 2022Anxiety DisordersSleep MedicinePain
Orally dissolving buprenorphine tied to severe tooth decay, FDA warnsJanuary 13, 2022Addiction MedicinePain
Study finds sharp drop in opioid scripts among most specialtiesJanuary 5, 2022PainAddiction MedicineMixed Topics
Califf plans work on opioids, accelerated approvals on return to FDADecember 16, 2021Business of MedicineMixed TopicsPainAlzheimer's & Cognition
Short-acting opioids needed for withdrawal in U.S. hospitals, say expertsNovember 23, 2021PainAddiction MedicineNeurology
Cannabis use: Messages remain mixed across diagnosesOctober 27, 2021Addiction MedicineAnxiety DisordersADHDPTSDSleep MedicineDepressionMajor Depressive Disorder
